Fu Yang

Assistant Professor
科研楼二号楼 B-512


Dr. Fu Yang obtained his BSc degree from School of Bio-Engineering, Jiangnan University in 2005 (Wuxi, Jiangsu, China) and PhD degree from School of Life Science,Nankai University (Tianjin, China) in 2013. During his PhD training, Dr. Fu enrolled in a visiting PhD student training program of Harvard Medical School from 2009 to 2013 and finished his thesis work at the U.S.After which, he did his postdoc training in the Department of Microbiology andImmunobiology of Harvard Medical School (US) from 2013 to 2019. Dr. Fu jointed SUSTech University as an Assistant Professor in July 2019. His research group employs microbiology,molecular genetics, systems biology and bioinformatics approaches to investigatebacterial inter/intra-species interactions, bacteria – host interactions, mechanisms of in vivo micro-ecological dysbiosis caused by bacterial infection or chronic diseases, unknown pathogenesis of the pathogens of emerging infectious diseases and next generation antimicrobial therapeutics.

Dr. Fu’s has long been involved in the research fields ofbacterial physiologyof enteric pathogens, bacterial Type IV and VI secretion systems, in vivo genes regulationwhich highly corelate to infection and immunity. Dr. Fu received the Fogarty Global Health fellowship from the U.S in 2008. He is currently an editor board member of Bio-Protocol. He has published 8 research papers in the famous international peer reviewed journals during last 5 years, including Cell Host and Microbe, Science Translational Medicine, Proc Natl Acad Sci U S A, Journal of Immunology, Vaccine, etc(Total citations > 300 since 2014). Dr. Fu has been invited to give conference talks at international conferences organized by academic societies such as American Society of Microbiology, Cold Spring Harbor, U.S – Japan Cooperative Medical Science Program / Pacific Rim Emerging Infectious Diseases, etc



1. Fu Y, Ho BT, & Mekalanos JJ (2018) Tracking Vibrio cholerae Cell-Cell Interactions during Infection Reveals Bacterial Population Dynamics within Intestinal Microenvironments. Cell host & microbe 23(2):274-281 e272. (IF: 17.87, Ranked 1st in Microbiology, Cell Press Sub-Publication)

2. Ho BT*, Fu Y*, Dong TG, & Mekalanos JJ (2017) Vibrio cholerae type 6 secretion system effector trafficking in target bacterial cells. Proceedings of the National Academy of Sciences of the United States of America 114(35):94279432. (IF: 9.5, Ranked 3rd in Life Science, Health & Medical Sciences [general]) * Co-First Authors

3. Fu Y# & Mekalanos JJ# (2014) Infant Rabbit Colonization Competition Assays. Bio Protoc 4(11). # Co-Corresponding Authors

4. Fu Y, Waldor MK, & Mekalanos JJ (2013) Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell host & microbe 14(6):652-663. (IF: 17.87, Ranked 1st in Microbiology, Cell Press Sub-Publication, Cited By 125)

5. Sanchez-Larrayoz AF, Elhosseiny, NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, and Maira-Litran T (2017) Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii
Needed for Survival in Human Serum. J Immunol 199, 2803-2814. (IF: 4.54, Ranked 6th in Immunology)

6. Roux, D, Danilchanka, O, Guillard, T, Cattoir, V, Aschard, H, Fu, Y, Angoulvant, F, Messika, J, Ricard, JD, Mekalanos, JJ, et al. (2015). Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med 7, 297ra114. (IF: 16.71, Ranked 10th in Health & Medical Sciences [general], Science Sub-Publication, Cited By 63)

7. Altindis E, Fu Y, & Mekalanos JJ (2014) Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proceedings of the National Academy of Sciences of the United States of America 111(15): E1548-1556. (IF: 9.5, Ranked 3rd in Life Science, Health & Medical Sciences [general], Cited by 74)

8. Liao Q, Strong A. J, Liu Y, Meng P, Fu Y, Touzjian N, Shao Y, Zhao Z, Lu Y (2012) HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques. Vaccine. 30(9): 1601-1608. (IF: 3.3, Ranked 3rd in Virology)